HealthBIO 2023 Partnering Event

7–14 Sept 2023 | Finland

Christopher Jonkergouw

Co-founder / CEO

Arivin therapeutics Oy

Espoo, Finland

12 profile visits

Arivin Therapeutics is a company that was founded on its scientific discoveries and its detailed knowledge on anti-infectives and drug development


Chris Jonkergouw (MSc University of Edinburgh, PhD Aalto University) has a strong background in biotechnology. Making the switch from science to business, he has managed the R2B funding drug development efforts (€1.200K budget), including contracts with CROs & CMOs, managing research & commercial, fundraising & investor relations. At Arivin, Chris is the CEO that oversees development efforts.

My organisation

Arivin therapeutics Oy

Social media


  • Antibiotic resistance
  • AMR
  • Anti-infectives
  • Drug Development


  • Seed round
  • Out-licensing